The wide-neck bifurcation aneurysms segment by application is estimated to lead the market growth during the forecast period.

According to a new market research study of “Asia Pacific Coil Assisted Flow Diverters Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Application, End User and Country.” The Asia Pacific coil assisted flow diverters market is expected to reach US$ 98.71 million in 2028 from US$ 57.01 million in 2021; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028. The report highlights trends prevailing in the Asia Pacific coil assisted flow diverters market and the factors driving market along with those that act as hindrances. Key factors that are driving growth of the market are rising incidence of intracranial aneurysms and growing incidence of hypertension, smoking, alcoholism, and obesity fuel the growth of the market. However, high cost of neurosurgical devices is expected to restrict the market growth during the forecast period.

Coil assisted flow diverters are stent-like devices that are used to for the embolization of intracranial aneurysms. Thus, increasing incidence of intracranial aneurysms is propelling the demand for coil assisted flow diverters. As per the Ministry of Health, Labor, and Welfare 2017 Survey, the number of patients suffering from cerebrovascular diseases, including subarachnoid hemorrhages and intracranial aneurysms, was estimated to be over 1.1 million in Japan. Thus, increasing prevalence of intracranial aneurysms is creating high demand for coil assisted flow diverters. Also, hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Thus, increasing prevalence of these diseases is likely to fuel the demand for coil assisted flow diverters. In addition to this, the growing geriatric population, the rise in associated neurological disorders and technological advancements in coil assisted flow diverters across Asia Pacific are likely to create growth opportunities for the market.

Asia Pacific countries are expecting to witness massive challenges due to increasing COVID-19. Due to the outbreak of disease, healthcare industries have been affected severely, considering the economic conditions in the current situation. As per the survey ‘Impact of the COVID-19 Pandemic on Neurosurgical Practice in India: Results of an Anonymized National Survey’, in India, there was drastic fall was observed in number of neurosurgical patients in the outpatient department (OPD) and in the number of surgeries performed. A drop of 76.25% was seen in OPD patients and 70.59% in surgeries performed. Also, universities across the Asia Pacific region are closed; access to research labs is restricted, and ongoing healthcare research and developments regarding coil assisted flow diverters have been postponed. Thus, the market is likely to face challenges due to coronavirus outbreak.

The Asia Pacific coil assisted flow diverters market, by application, is segmented into wide-neck bifurcation aneurysms, and narrow bifurcation aneurysms. Based on end user, the Asia Pacific coil assisted flow diverters market is segmented into hospitals, clinics, and ambulatory surgical centers. Geographically, the Asia Pacific coil assisted flow diverters market can be bifurcated into China, Japan, India, Australia, South Korea and Rest of Asia Pacific.

Balt USA LLC, MicroPort Scientific Corporation, Stryker Corporation, Penumbra, Inc, Medtronic, Acandis GmbH, MicroVention Inc, Johnson and Johnson Services, Inc., Lepu Medical Technology Co. Ltd., and Cerus Endovascular are among the leading companies operating in the Asia Pacific coil assisted flow diverters market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com